Next-generation ADC platform

Modular combination of payload, linker, and antibody to derive disease-optimized IM-ADCs (immunomodulatory ADCs) Immune cellmodulation technology:Discovery of specific payloads that remodel the tumor microenvironment, using animal models of human disease • ALS-based TPD (ATTEC): A differentiated targeted protein degradation technologythat routes proteins resistant to the conventionalUPS pathway through autophagy-lysosomal degradation instead • AI-driven drug design (AIDD)